A rare case of takotsubo syndrome within the first day after heart transplantation

A 39-year-old woman underwent heart transplantation (HTx) for advanced heart failure. The donor was a 36-year-old young woman without past medical history. The first day after HTx, T-waves changes were noted. Echocardiography revealed akinesia/dyskinesia of all basal segments of the two ventricles....

Full description

Saved in:
Bibliographic Details
Published in:Monaldi archives for chest disease 2019-10, Vol.89 (3)
Main Authors: Al Humaid, Mohammed, Ahmed, Mawada, Galzerano, Domenico, Al Hussein, Mosaad, Al Admawi, Mohammed, Al Buraiki, Jehad, Alsergani, Hani, Vriz, Olga
Format: Article
Language:English
Subjects:
Adrenal Medulla - metabolism
Adult
cardiomyopathy
Cardiotonic Agents - therapeutic use
Catecholamines - blood
Female
Heart Failure - surgery
Heart transplant
Heart Transplantation - adverse effects
Heart Ventricles - diagnostic imaging
Heart Ventricles - physiopathology
Humans
Postoperative Complications - diagnostic imaging
Postoperative Complications - physiopathology
Stress, Physiological
takotsubo
Takotsubo Cardiomyopathy - diagnostic imaging
Takotsubo Cardiomyopathy - etiology
Takotsubo Cardiomyopathy - physiopathology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A 39-year-old woman underwent heart transplantation (HTx) for advanced heart failure. The donor was a 36-year-old young woman without past medical history. The first day after HTx, T-waves changes were noted. Echocardiography revealed akinesia/dyskinesia of all basal segments of the two ventricles. Coronary catheterization plus biopsy were done 7 days later showing no coronary obstruction, no rejection and complete recovery of wall motion abnormalities on echocardiogram, suggesting biventricular inverted takotsubo syndrome (TTS). This is a case of TTS during the first day after HTx, with completely denervated heart but because of the inotropic drug support it still represents a target for catecholamine-induced cardiac dysfunction.
ISSN:1122-0643
2532-5264
DOI:10.4081/monaldi.2019.1149